🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareMy 18-month semaglutide journey — comprehensive data log Page 3

My 18-month semaglutide journey — comprehensive data log

DataDave Sun, Jun 7, 2026 at 11:03 AM 20 replies 526 viewsPage 3 of 4
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Jun 8, 2026 at 1:24 PM#11
SleepDoc_PDX said:
It helps to ask what evidence would change your mind before you look at any.

All true, with one condition: that curve is for people who reached the dose on schedule. Anyone who slowed the ladder for tolerability is on a different, flatter curve, and comparing yourself with the published mean will make you feel like a non-responder when you are not.

Last edited: Jun 8, 2026 at 7:24 PM
6 6EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 3 others
Reply Quote Save Share Report
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Jun 8, 2026 at 2:15 PM#12
BiostatsBrad said:
The mechanism that matters here is not stomach emptying, it is central.

This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.

Last edited: Jun 8, 2026 at 4:15 PM
5 5labquiet_amy, emily_PDX, Dr.SleepRoch and 2 others
Reply Quote Save Share Report
tommy_boulder
Member
234
1,123
Nov 2024
Boulder, CO
Jun 8, 2026 at 3:06 PM#13
SleepDoc_PDX said:
It helps to ask what evidence would change your mind before you look at any.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

Last edited: Jun 8, 2026 at 4:06 PM
4 4robert_kc, dan_philly, MeganSA_TX and 1 other
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Jun 8, 2026 at 3:57 PM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Last edited: Jun 8, 2026 at 9:57 PM
3 3andrew_nyc, Dr.EndoEP, GraceAZ_72
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 8, 2026 at 4:48 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

2 2PurityPaulOR, MaxMetOK
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
What I wish I knew before starting GLP-1 therapy14 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register